eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Stocks-TGTX-TG Therapeutics Inc.

TG Therapeutics Inc. TGTX

‎$‎28.47-2.03(-6.66%)(1D)
Delayed prices by NASDAQin USD
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
53.00
Based on analysts who covered TGTX
Invest in TG Therapeutics Inc.
Today
Create an eToro account to buy TGTX stock on a secure, user-friendly, multi-asset trading platform.
Buy TG Therapeutics Inc.
TG Therapeutics Inc. TGTX

TGTX Stock Price Chart

‎-7.59‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset negative trend

The TG Therapeutics Inc. share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The TG Therapeutics Inc. share price today is ‎$‎28.47, reflecting a ‎-6.66‎% change over the last 24 hours and ‎-2.63‎% over the past week. The current market capitalization of TGTX is ‎$‎4.52B with an average volume in the last three months of 1.8M. The stock has a P/E ratio of 10.25 and a dividend yield of 0%. With the stock’s beta sitting at 1.14
TGTX Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎4.52B

Day’s Range
i
Shows the high and low prices of the day.
‎$‎28.16 - ‎$‎30.69

52W Range
i
Shows the high and low prices of the last year.
‎$‎16.65 - ‎$‎46.35

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.8M

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
10.25

Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎531.9M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎28.47

EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎2.78

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.14

How can I buy TG Therapeutics Inc. stocks?

To purchase TG Therapeutics Inc.:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the TG Therapeutics Inc. (TGTX) page and place an order to buy TG Therapeutics Inc..
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
AI Stocks Poised for Growth in 2026
AI Stocks Poised for Growth in 2026
Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Graph
Buy TG Therapeutics Inc.
Invest in TG Therapeutics Inc.
Today
Create an eToro account to buy TGTX stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of TGTX is ‎$‎28.47.
The average price target for TG Therapeutics Inc. is ‎$‎53.00. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for TG Therapeutics Inc. based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of TG Therapeutics Inc. is ‎$‎4.52B
Based on 3 analysts offering recommendations for TGTX in the last 3 months, the overall consensus is Strong Buy.
Scroll to top